A detailed history of Allworth Financial LP transactions in Biodesix Inc stock. As of the latest transaction made, Allworth Financial LP holds 99,331 shares of BDSX stock, worth $137,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares
99,331
Previous 99,331 -0.0%
Holding current value
$137,076
Previous $151,000 16.56%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$1.35 - $2.12 $58,695 - $92,173
43,478 Added 77.84%
99,331 $142,000
Q2 2022

Jul 13, 2022

BUY
$1.32 - $2.12 $73,725 - $118,408
55,853 New
55,853 $92,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.